Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 106617
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.106617
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.106617
Figure 4 Myosin heavy chain 9 activates pan-mitogen-activated protein kinase signaling molecules, including extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase.
This activation leads to the induction of nuclear factor erythroid-derived 2 transcriptional activity, the upregulation of the antioxidant enzymes, and the reduction of cellular reactive oxygen species levels. The antioxidant enzyme, such as glutamate-cysteine ligase catalytic subunit, further confers cell invasion and radioresistance, resulting in aggressive cancer and poor prognosis. MYH9: Myosin heavy chain 9; MAPK: Mitogen-activated protein kinases; Nrf2: Nuclear factor erythroid-derived 2; ARE: Antioxidant response element; ROS: Reactive oxygen species; GCLC: Glutamate-cysteine ligase catalytic subunit; GCLM: Glutamate-cysteine ligase modifier subunit.
- Citation: Zeng XF, Wang YW, Ou Y, Liu L. Role of myosin heavy chain 9 in gastrointestinal tumorigenesis: A comprehensive review. World J Gastrointest Oncol 2025; 17(6): 106617
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/106617.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.106617